首页> 外文期刊>Integrative Medicine Research >Acute toxicity and genotoxicity of fermented traditional medicine oyaksungi-san
【24h】

Acute toxicity and genotoxicity of fermented traditional medicine oyaksungi-san

机译:发酵传统药御茶山的急性毒性和遗传毒性

获取原文
           

摘要

Abstract Background The traditional medicine oyaksungi-san (OY) has been prescribed in East Asia for hundreds of years for the treatment of stroke, paralysis, and ataxia. {OY} also has therapeutic effects on arthralgia, myalgia, and rheumatoid arthritis, and recent studies have shown its protective effects against apoptosis of hippocampal cells and its anti-inflammatory effects on the peripheral blood cells of patient with cerebral infarction. Many studies have explored the use of traditional medicine and herb materials in the development of safe, novel, and effective pharmaceuticals with fewer side effects. These efforts commonly adopt a bioconversion tool for fermentation with beneficial microbes. However, only pharmaceuticals with high levels of safety and low levels of toxicity can be used in healthcare system. Methods {OY} water extract was fermented with Lactobacillus and assayed for acute toxicity and genotoxicity. Single dose acute toxicity, bacterial reverse mutation, chromosome aberrations, and micronucleus were observed and assayed in rats, histidine/tryptophan auxotrophic bacteria, Chinese hamster ovary fibroblast cells, and mice bone marrow cells, respectively. Results All the experimental animals showed no abnormal behavior, clinical signs, body weight increases, or mortality. In the bacterial cultures, no revertant colonies were observed. Morphological and numerical chromosomal aberrations were not found in all metaphases examined. Frequency of induced micronuclei was not significantly increased in all doses applied. Conclusion As a whole, no acute toxicity or genotoxicity were observed in all the assays examined. Therefore, fermented {OY} is considered to be a safe material that can be used for development of complementary and alternative medicine using bioconversion.
机译:摘要背景东亚已开出数百年的传统药物oyaksungi-san(OY),用于治疗中风,瘫痪和共济失调。 {OY}对关节痛,肌痛和类风湿性关节炎也有治疗作用,最近的研究表明其对海马细胞凋亡的保护作用以及对脑梗死患者外周血细胞的抗炎作用。许多研究探索了使用传统药物和草药材料开发安全,新颖,有效且副作用少的药物。这些努力通常采用生物转化工具与有益微生物发酵。但是,只有高安全性和低毒性的药物才能用于医疗保健系统。方法将{OY}水提取物用乳酸菌发酵,并测定其急性毒性和遗传毒性。分别在大鼠,组氨酸/色氨酸营养缺陷型细菌,中国仓鼠卵巢成纤维细胞和小鼠骨髓细胞中观察并测定了单剂量急性毒性,细菌反向突变,染色体畸变和微核。结果所有实验动物均未表现出异常行为,临床体征,体重增加或死亡率。在细菌培养物中,未观察到回复菌落。在所检查的所有中期均未发现形态学和数字染色体畸变。在所有剂量下诱导微核的频率均未显着增加。结论总体而言,在所有检测方法中均未观察到急性毒性或遗传毒性。因此,发酵的{OY}被认为是一种安全的材料,可用于利用生物转化技术开发补充和替代药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号